Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.
| Revenue (TTM) | $1.50B |
| Gross Profit (TTM) | $488.62M |
| EBITDA | $234.75M |
| Operating Margin | 12.60% |
| Return on Equity | 30.30% |
| Return on Assets | 8.40% |
| Revenue/Share (TTM) | $37.00 |
| Book Value | $8.20 |
| Price-to-Book | 4.49 |
| Price-to-Sales (TTM) | 1.08 |
| EV/Revenue | 1.556 |
| EV/EBITDA | 10.52 |
| Quarterly Earnings Growth (YoY) | 15.70% |
| Quarterly Revenue Growth (YoY) | 10.30% |
| Shares Outstanding | $21.07M |
| Float | $20.85M |
| % Insiders | 0.99% |
| % Institutions | 99.54% |
Volatility is currently expanding